Showing 20 of 136 recruiting trials for “hepatocellular-adenoma”
RecruitingNCT07100405 ↗
TACE Combined With Anti-PD-1 Antibody in Patients With Advanced Hepatocellular Carcinoma: Study on Efficacy and Immune Microenvironment
MDN-001 Injection for the Treatment of Unresectable Primary Hepatocellular Carcinoma.
To Test Whether Time-restricted Eating Coupled With a Healthy Diet is Beneficial in Liver Cancer Patients
RecruitingNCT07345247 ↗
RAdiation SEgmentectomy With REsin Microspheres (RASEREM) Study
Application of mRNA Vaccine in Liver Transplantation for Hepatocellular Carcinoma
Continuation of First-line Therapy With Radiotherapy Versus Early Switch to Second-line Therapy in Oligoprogressive HCC
👨⚕️ Jinbo Yue, Doctor, Shandong Cancer Hospital and Institute📍 1 site📅 Started Jul 2025View details ↗
Study of GV20-0251 in Participants With Solid Tumor Malignancies
Peptide Vaccine for Fibrolamellar Hepatocellular Carcinoma Patients and Other Tumor Entities Carrying the Driver Fusion DNAJB1-PRKACA
A Study to Evaluate CG-102-12C in Glypican-3 (GPC3) Positive Advanced Hepatocellular Carcinoma (HCC)
PIN in Combination With Anti-PD1 in Previously Treated Primary Hepatocellular Carcinoma
👨⚕️ Weidong Han, Ph.D, Biotherapeutic Department, Chinese PLA General Hospital📍 1 site📅 Started Jun 2025View details ↗
Testing the Addition of an Anti-cancer Drug, DT2216, to the Usual Chemotherapy Treatment for Relapsed or Refractory Solid Tumors and Fibrolamellar Carcinoma
👨⚕️ Michael V Ortiz, Pediatric Early Phase Clinical Trial Network📍 20 sites📅 Started Jun 2025View details ↗
Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells
RecruitingNCT06877637 ↗
On-treatment Surveillance of Tumor Evolution and Response to Systemic Treatment in Bile Duct and Liver Cancer
Hyperpolarized 13C-MRI in Patients With Hepatocellular Carcinoma Undergoing Radiotherapy, Atezolizumab, and Bevacizumab
RecruitingNCT06999174 ↗
Multiparametric MRI for Characterization of Hepatocellular Carcinoma
Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations
Lenvatinib, Sintilimab, and DEB-TACE With/Without HAIC for HCC >7 cm With PVTT
👨⚕️ Kangshun Zhu, Dr., Second Affiliated Hospital of Guangzhou Medical University📍 1 site📅 Started Apr 2025View details ↗
First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid Tumours
Microbiota Modification for Immuno-oncology in Hepatocellular Carcinoma
👨⚕️ Héloise BOURIEN, Dr, Centre de lutte contre le cancer Eugène Marquis📍 6 sites📅 Started Mar 2025View details ↗
A Phase II Single-Arm Clinical Study to Evaluate the Efficacy and Safety of Carbon Ion Radiotherapy With Atezolizumab and Bevacizumab Combination Therapy in Patients With Advanced Hepatocellular Carcinoma
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →